Enea S.A. — Regulatory Filings 2018

Feb 22, 2018

Current Report No.: 4/2018

Date of preparation: February 21st, 2018

Short name of issuer: Enea S.A.

Subject: Notification about preliminary results of works related toimpairment tests, resulting in a probable reversal of impairment losseson shares in Enea Wytwarzanie Sp. z o.o. in non-consolidated financialstatements

Legal basis: Article 17, Section 1 of the Market Abuse Regulation -confidential information

Content of report:

The Management Board of Enea S.A. (Issuer, Company) in relation to thecurrent report No. 10/2016 of March 4, 2016 informs that in connectionwith the preliminary results of works related to impairment tests forshares in Enea Wytwarzanie Sp. z o.o. in accordance with therequirements of IAS 36, on February 21, 2018, it was informed about theprobable need to include in the books of the Issuer PLN 879.27 milliondue to the reversal of write-downs of the balance sheet value of sharesin Enea Wytwarzanie Sp. z o.o. made in previous years.

At the same time, the Issuer points out that the above-mentionedoperation is of an accounting nature, does not affect the liquidityposition of the Company and will not affect the consolidated financialresults of the Enea Capital Group. The company reserves that valuespresented above are estimates and are subject to change. Final testresults and amounts included in the accounting books will be presentedin the non-consolidated financial statements of Enea S.A. for the year2017, the publication of which is scheduled for March 23, 2018.

As a result of this situation, the Company informs that the publicationof the preliminary financial results for 2017 will take place at thelatest on March 1, 2018.